Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies
Abstract The mRNA vaccine platform has offered the greatest potential in fighting the COVID-19 pandemic owing to rapid development, effectiveness, and scalability to meet the global demand. There are many other mRNA vaccines currently being developed against different emerging viral diseases. As wit...
Main Authors: | Sodiq A. Hameed, Stephane Paul, Giann Kerwin Y. Dellosa, Dolores Jaraquemada, Muhammad Bashir Bello |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-06-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-022-00485-x |
Similar Items
-
Mucosal Vaccines against Bacterial and Viral Pathogens
by: A. N. Suvorov, et al.
Published: (2023-09-01) -
Mucosal immunity and vaccines against viral infections
by: S. S. Zainutdinov, et al.
Published: (2022-01-01) -
Next Generation Mucosal Vaccine Strategy for Respiratory Pathogens
by: Farokh Dotiwala, et al.
Published: (2023-10-01) -
Editorial: Mucosal Vaccination: Strategies to Induce and Evaluate Mucosal Immunity
by: Pamela A. Kozlowski, et al.
Published: (2022-04-01) -
Mucosal vaccination: onward and upward
by: Catherine J. Y. Tsai, et al.
Published: (2023-12-01)